http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010118024-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate | 2008-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2010118024-A |
titleOfInvention | COMPOSITION FOR TREATMENT OF LUNG CANCER, FIRST OF ALL, NON-SMALL CELL LUNG CANCER (NSCLC) |
abstract | 1. An active (immunostimulating) composition comprising at least one RNA encoding at least two different antigens! a) where at least one of the at least two antigens selected from:! NY-ESO-1,! MAGE-C1 and / or! MAGE-C2, and! b) where another antigen (s) are selected (selected) from at least one antigen selected from the following group, including:! hTERT,! WT1,! MAGE-A2,! 5T4,! MAGE-A3,! MUC1,! Her-2 / neu,! NY-ESO-1,! CEA! survivin! MAGE-C1 and / or! MAGE-C2. ! 2. The active (immunostimulating) composition according to claim 1, where at least one of at least two different antigens in paragraph a) is selected from! MAGE-C1 and / or! MAGE-C2. ! 3. The active (immunostimulating) composition according to claim 1, where the other antigen (s) in paragraph b) is selected exclusively from the following combination of antigens:! hTERT and WT1 or! hTERT and MAGE-A2, or! hTERT and 5T4, or! hTERT and MAGE-A3, or! rTERT and MGS1, or! hTERT and Her-2 / neu, or! hTERT and NY-ESO-1, or! hTERT and CEA, or! hTERT and survivin, or! hTEPT and MAGE-C1, or! hTERT and MAGE-C2, or! WT1 and MAGE-A2, or! WT1 and 5T4, or! WT1 and MAGE-A3, or! WT1 and MUC1, or! WT1 and Her-2 / neu, or! WT1 and NY-ESO-1, or! WT1 and CEA, or! WT1 and survivin, or! WT1 and MAGE-C1, or! WT1 and MAGE-C2, or! MAGE-A2 and 5T4, or! MAGE-A2 and MAGE-A3, or! MAGE-A2 and MUC1, or! MAGE-A2 and Her-2 / neu, or! MAGE-A2 and NY-ESO-1, or! MAGE-A2 and CEA, or! MAGE-A2 and survivin, or! MAGE-A2 and MAGE-C1, or! MAGE-A2 and MAGE-C2, or! 5T4 and MAGE-A3, or! 5T4 and MUC1, or! 5T4 and Her-2 / neu, or! 5T4 and NY-ESO-1, or! 5T4 and CEA, or! 5T4 and survivin, or! 5T4 and MAGE-C1, or! 5T4 and MAGE-C2, or! MAGE-A3 and MUC1, or! MAGE-A3 and Her-2 / neu, or! MAGE-A3 and NY-ESO-1, or! MAGE-A3 and CEA, or! MAGE-A3 and survivin, or! MAGE-A3 and MAGE-C1! MAGE-A3 and MAGE-C2! MUC1 and Her-2 / neu, or! MUC1 and NY-ESO-1, or! MUC1 and CEA, or! MUC1 and survivin, or! MUC1 and MAGE-C1, or! MUC1 and MAGE-C2, or! HER-2 / NEU and NY-ESO-1, or! HER-2 / NEU and CEA, or! HER-2 / NEU and survivin, or! HER-2 / NEU and MAGE-C1, or! HER- |
priorityDate | 2007-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 181.